Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0003353
UniProt IDP61981
Primary gene name(s)YWHAG
Synonym gene name(s)unknown
Protein name14-3-3 protein gamma
Protein functionAdapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. {ECO:0000269|PubMed:16511572}.
Subcellular locationCytoplasm {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P61981
Gene Ontology
(Biological Process)
Complete annatation
cellular response to insulin stimulus [GO:0032869];
G2/M transition of mitotic cell cycle [GO:0000086];
membrane organization [GO:0061024];
negative regulation of protein kinase activity [GO:0006469];
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];
protein targeting [GO:0006605];
regulation of neuron differentiation [GO:0045664];
regulation of signal transduction [GO:0009966];
regulation of synaptic plasticity [GO:0048167]
Gene Ontology
(Molecular Function)
Complete annatation
insulin-like growth factor receptor binding [GO:0005159];
poly(A RNA binding [GO:0044822];
protein kinase C binding [GO:0005080];
protein kinase C inhibitor activity [GO:0008426]
Gene Ontology
(Cellular Component)
Complete annatation
cytoplasmic vesicle membrane [GO:0030659];
cytosol [GO:0005829];
extracellular exosome [GO:0070062];
focal adhesion [GO:0005925];
membrane [GO:0016020];
mitochondrion [GO:0005739];
myelin sheath [GO:0043209]
Protein-protein interaction113364
Phylogenetic treeP61981
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.718973547279883.14155349623313e-072.72242298162011e-06
AZA vs. DISU0.2807842355819660.2669589108916280.843267472087723
AZA vs. IL70.3682884322624830.05563488482027260.686142885704394
AZA vs. SAHA0.02416161570014710.9210743209955320.982071981797342
DISU vs. CD3-1.450769078782928.48133222942637e-050.000490777742903544
DISU vs. IL70.07841426036397150.7553248369225130.941464027786899
DISU vs. SAHA-0.2551536177520630.3810543155288160.747956662720956
DMSO vs. AZA-0.0172695925211280.91795166251611
DMSO vs. CD3-1.746329469358561.05619471502116e-079.26707826545942e-07
DMSO vs. DISU-0.2997507531800060.2192557758773160.731297416383213
DMSO vs. IL70.3928098300901250.02909316146977630.34670309024259
DMSO vs. SAHA0.03433929425449860.8841524885397960.971193040903484
HIV vs. Mock in Activation0.2296307704574510.7118925791115870.999983755607037
HIV vs. Mock in Latency-0.03904276662239280.8130353247290880.999834320637052
IL7 vs. CD3-1.343157426696683.83818730981256e-050.000251863288292576
SAHA vs. CD3-1.719031009605952.13307845498001e-061.60727461582744e-05
SAHA vs. IL7-0.3472241568050090.1540870555836410.372169247855761
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
-0.2948 0.04539

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.166625 0.251629
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.016 0.945 1.048 1.064 0.928
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
2B05 X-ray 2.5Å A/B/C/D/E/F=2-247.
3UZD X-ray 1.8Å A=1-247.
4E2E X-ray 2.2Å A=1-247.
4J6S X-ray 3.0Å A/B/C/D=1-247.
4O46 X-ray 2.9Å A/B/C/D/E/F=1-247.
5D3E X-ray 2.7Å A/B/E/F/I/J=1-238.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Vpr enhanced by 11531413
integrase interacts with 22190034
Vpr inhibits 15265780
Tat downregulates 23166591

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04110 Cell cycle - Homo sapiens (human)
hsa04114 Oocyte meiosis - Homo sapiens (human)
hsa04151 PI3K-Akt signaling pathway - Homo sapiens (human)
hsa04390 Hippo signaling pathway - Homo sapiens (human)
hsa05169 Epstein-Barr virus infection - Homo sapiens (human)
hsa05203 Viral carcinogenesis - Homo sapiens (human)